Bax-Induction Gene Therapy of Pancreatic Cancer

Author： Pirocanac E.C.   Nassirpour R.   Yang M.   Wang J.   Nardin S.R.   Gu J.   Fang B.   Moossa A.R.   Hoffman R.M.   Bouvet M.  

Publisher： Academic Press

ISSN： 0022-4804

Source： Journal of Surgical Research, Vol.106, Iss.2, 2002-08, pp. : 346-351

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Somatostatin Receptor Subtype 2 Gene Therapy Inhibits Pancreatic Cancer in Vitro

By Fisher W.E.   Wu Y.   Amaya F.   Berger D.H.  

Journal of Surgical Research, Vol. 105, Iss. 1, 2002-06 ,pp. : 58-64

Academic Press

Access to resources Recommend Favorite

Hypericin and Photodynamic Therapy Decreases Human Pancreatic Cancer in Vitro and in Vivo

By Liu C.D.   Kwan D.   Saxton R.E.   McFadden D.W.  

Journal of Surgical Research, Vol. 93, Iss. 1, 2000-09 ,pp. : 137-143

Academic Press

Access to resources Recommend Favorite

Can Expression of Apoptosis Genes, bcl-2 and bax, Predict Survival and Responsiveness to Chemotherapy in Node-Negative Breast Cancer Patients?

By Kymionis G.D.   Dimitrakakis C.E.   Konstadoulakis M.M.   Arzimanoglou I.   Leandros E.   Chalkiadakis G.   Keramopoulos A.   Michalas S.  

Journal of Surgical Research, Vol. 99, Iss. 2, 2001-08 ,pp. : 161-168

Academic Press

Access to resources Recommend Favorite

Current status of gene therapy for pancreatic cancer

By Ramirez P.J.   Vickers S.M.  

Current Surgery, Vol. 61, Iss. 1, 2004-01 ,pp. : 84-92

Elsevier

Access to resources Recommend Favorite

Adenoviral Gene Therapy for Pancreatic Cancer: Where Do We Stand?

By  

Digestive Surgery, Vol. 25, Iss. 4, 2008-07 ,pp. : 278-292

Karger

Access to resources Recommend Favorite